Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2022	Oct. 01, 2021
Cash flow from operating activities:
Net income	$ 5,382	$ 5,013
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization expense	2,051	2,451
Equity-based compensation expense	1,869	1,974
Deferred income taxes	(138)	(269)
Deferred compensation benefits	(152)	(42)
Loss on the sale of property and equipment		13
Changes in assets and liabilities that provide (use) cash, excluding the effects of acquisitions:
Accounts receivable	11,614	(6,803)
Prepaid and other current assets	(395)	(847)
Other long-term assets	(41)	(448)
Cash surrender value of life insurance	525	130
Accounts payable	(10,159)	(6,514)
Accrued compensation	(63)	7,826
Income taxes payable / receivable	1,189	145
Advance billings on contracts	670	53
Other current liabilities	151	(440)
Other long-term liabilities	6	(9)
Net cash provided by operating activities	12,509	2,233
Cash flow from investing activities:
Cash paid for acquisitions, net of cash acquired	(16,568)
Additions to property and equipment	(479)	(1,447)
Additions to capitalized software	(285)
Proceeds from sale of property & equipment	9
Premiums paid for life insurance	(594)	(531)
Net cash used in investing activities	(17,917)	(1,978)
Cash flow from financing activities:
Deferred debt financing costs		(1,274)
Proceeds from stock option plan exercises	215	366
Taxes remitted for shares withheld from equity-based compensation transactions	(1,230)	(389)
Proceeds from Employee Stock Purchase Plan	131	122
Net cash used in financing activities	(884)	(1,175)
Effect of exchange rates on cash and cash equivalents	(2,539)	(917)
Net decrease in cash and cash equivalents	(8,831)	(1,837)
Cash and cash equivalents at beginning of year	35,584	32,865
Cash and cash equivalents at end of quarter	26,753	$ 31,028
Supplemental disclosure of non-cash transactions
Acquisition share issuance	1,178
Acquisition stock option issuance	$ 391